We have identified KMT2C SET domain deletion as a driving event of metastatic PCa in our murine model system and have observed an enrichment of the MYC gene signature accompanied by concurrent loss of p16INK4A as mechanistic downstream effects. The gene discussed is MYC; the disease is posterior cortical atrophy.